EPISODE · Mar 2, 2026 · 18 MIN
Special Series| AI Reckoning Ep 1: The Reckoning — 5% of Pharma Has AI Advantage, 95% Still Running Pilots
from The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus · host BZ Group
Only 5% of pharma companies have turned AI into competitive advantage. 89% of AI pilots fail to scale. The gap is widening, not closing. We unpack the $6.6B market reality, what "production scale" actually means vs. what companies claim, why 80% of AI transformation is organizational change not technology, the skills half-life crisis (2-5 years by 2030), and the board governance vacuum. Episode 1 of our 4-part special series "The AI Reckoning: Pharma's Make-or-Break Moment."
What this episode covers
Only 5% of pharma companies have turned AI into competitive advantage. 89% of AI pilots fail to scale. The gap is widening, not closing. We unpack the $6.6B market reality, what "production scale" actually means vs. what companies claim, why 80% of AI transformation is organizational change not technology, the skills half-life crisis (2-5 years by 2030), and the board governance vacuum. Episode 1 of our 4-part special series "The AI Reckoning: Pharma's Make-or-Break Moment."
NOW PLAYING
Special Series| AI Reckoning Ep 1: The Reckoning — 5% of Pharma Has AI Advantage, 95% Still Running Pilots
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m